PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
510.13%
Some net income increase while JD is negative at -1336.80%. John Neff would see a short-term edge over the struggling competitor.
9.57%
Less D&A growth vs. JD's 615.60%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
401.59%
Deferred tax of 401.59% while JD is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
11.40%
Less SBC growth vs. JD's 287.33%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
331.14%
Working capital change of 331.14% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-100.34%
AR is negative yoy while JD is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
12.62%
Inventory growth of 12.62% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
202.46%
AP growth of 202.46% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
121.54%
Growth of 121.54% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-52.25%
Negative yoy while JD is 358.25%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
237.62%
Operating cash flow growth above 1.5x JD's 5.78%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-9.54%
Both yoy lines negative, with JD at -20.32%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-201.90%
Negative yoy acquisition while JD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-21.12%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
8.61%
Liquidation growth of 8.61% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-190.91%
Both yoy lines negative, with JD at -352.60%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-34.35%
Both yoy lines negative, with JD at -208.55%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-96.97%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.